{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T20:38:39Z","timestamp":1782160719703,"version":"3.54.5"},"reference-count":64,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2017,2,8]],"date-time":"2017-02-08T00:00:00Z","timestamp":1486512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"name":"M\u00e9decins Sans Fronti\u00e8res (MSF)"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0171124","type":"journal-article","created":{"date-parts":[[2017,2,8]],"date-time":"2017-02-08T18:28:58Z","timestamp":1486578538000},"page":"e0171124","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-na\u00efve persons in rural western Kenya"],"prefix":"10.1371","volume":"12","author":[{"given":"Harris","family":"Onywera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Maman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Inzaule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erick","family":"Auma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kennedy","family":"Were","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harrison","family":"Fredrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prestone","family":"Owiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valarie","family":"Opollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Etard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Mukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea A.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clement","family":"Zeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,2,8]]},"reference":[{"issue":"10","key":"ref1","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJMra025195","article-title":"HIV Drug Resistance","volume":"350","author":"F Clavel","year":"2004","journal-title":"N Engl J Med"},{"key":"ref2","unstructured":"UNAIDS. Global Report: UNAIDS Report on the Global AIDS Epidemic 2013. 2013."},{"key":"ref3","unstructured":"NASCOP. Kenya AIDS Indicator Survey 2012: Preliminary Report. 2013."},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2217\/hiv.09.30","article-title":"Transmitted Drug Resistance in Nonsubtype B HIV-1 Infection","volume":"3","author":"PA Chan","year":"2009","journal-title":"HIV Ther"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/COH.0b013e32835b7f94","article-title":"Emerging HIV-1 Drug Resistance after Roll-out of Antiretroviral Therapy in sub-Saharan Africa","volume":"8","author":"RL Hamers","year":"2013","journal-title":"Curr Opin HIV AIDS"},{"issue":"17","key":"ref6","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1097\/QAD.0b013e32834bbbe9","article-title":"Scale-up of Antiretroviral Treatment in sub-Saharan Africa is Accompanied by Increasing HIV-1 Drug Resistance Mutations in Drug-Na\u00efve Patients","volume":"25","author":"AF Aghokeng","year":"2011","journal-title":"AIDS"},{"issue":"9849","key":"ref7","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0140-6736(12)61038-1","article-title":"Global Trends in Antiretroviral Resistance in Treatment-Na\u00efve Individuals with HIV after Rollout of Antiretroviral Treatment in Resource-Limited Settings: A Global Collaborative Study and Meta-Regression Analysis","volume":"380","author":"RK Gupta","year":"2012","journal-title":"Lancet"},{"issue":"12","key":"ref8","doi-asserted-by":"crossref","first-page":"e15510","DOI":"10.1371\/journal.pone.0015510","article-title":"Transmitted Drug Resistance in Persons with Acute\/Early HIV-1 in San Francisco, 2002\u20132009","volume":"5","author":"V Jain","year":"2010","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"E169","DOI":"10.1111\/1469-0691.12124","article-title":"High Rates of Transmitted Drug Resistance among Newly-Diagnosed Antiretroviral Na\u00efve HIV Patients in Northern Greece, Data from 2009\u20132011","volume":"19","author":"L Skoura","year":"2013","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/aid.2010.0030","article-title":"Transmitted HIV Type 1 Drug Resistance among Individuals with Recent HIV Infection in East and Southern Africa","volume":"27","author":"MA Price","year":"2011","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"7","key":"ref11","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/QAD.0b013e328346260f","article-title":"Transmitted Antiretroviral Drug Resistance among Newly HIV-1 Diagnosed Young Individuals in Kampala","volume":"25","author":"N Ndembi","year":"2011","journal-title":"AIDS"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/QAI.0b013e3182618f05","article-title":"Prevalence of Transmitted Antiretroviral Drug Resistance Differs between Acutely and Chronically HIV-Infected Patients","volume":"61","author":"EL Yanik","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1177\/135965350901400503","article-title":"Transmitted Antiretroviral Drug Resistance among Acute and Recent HIV Infections in North Carolina, 1998 to 2007","volume":"14","author":"CB Hurt","year":"2010","journal-title":"Antivir Ther"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1086\/650001","article-title":"Transmission of HIV-1 Drug-Resistant Variants: Prevalence and Effect on Treatment Outcome","volume":"50","author":"MR Jakobsen","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"9400","key":"ref15","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/S0140-6736(03)15022-2","article-title":"Treatment of Antiretroviral-Drug-Resistant HIV-1 Infection","volume":"362","author":"SG Deeks","year":"2003","journal-title":"Lancet"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1089\/aid.2012.0167","article-title":"Low Prevalence of Transmitted HIV Type 1 Drug Resistance among Antiretroviral-Na\u00efve Adults in a Rural HIV Clinic in Kenya","volume":"29","author":"AS Hassan","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/01.aids.0000433239.01611.52","article-title":"Averted HIV Infections Due To Expanded Antiretroviral Treatment Eligibility Offsets Risk of Transmitted Drug Resistance: A Modeling Study","volume":"28","author":"BE Nichols","year":"2014","journal-title":"AIDS"},{"key":"ref18","unstructured":"UNAIDS\/WHO. When and How to Use Assays for Recent Infection to Estimate HIV Incidence at a Population Level. 2011."},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1086\/375597","article-title":"Antiretroviral Drug Resistance Testing in Adults Infected with Human Immunodeficiency Virus Type 1: 2003 Recommendations of an International AIDS Society-USA Panel","volume":"37","author":"MS Hirsch","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"ref20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/135965350801302S04","article-title":"Recommendations for Surveillance of Transmitted HIV Drug Resistance in Countries Scaling up Antiretroviral Treatment","volume":"13","author":"DE Bennett","year":"2008","journal-title":"Antivir Ther"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1177\/135965350801300502","article-title":"The Status of HIV-1 Resistance to Antiretroviral Drugs in sub-Saharan Africa","volume":"13","author":"RL Hamers","year":"2008","journal-title":"Antivir Ther"},{"issue":"Suppl 2","key":"ref22","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1093\/infdis\/jit111","article-title":"Transmission of Drug Resistant HIV and its Potential Impact on Mortality and Treatment Outcomes in Resource-Limited Settings","volume":"207","author":"V Cambiano","year":"2013","journal-title":"J Infect Dis"},{"issue":"6","key":"ref23","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1056\/NEJMoa013552","article-title":"Antiretroviral-Drug Resistance among Patients Recently Infected with HIV","volume":"347","author":"SJJ Little","year":"2002","journal-title":"N Engl J Med"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1473-3099(11)70032-9","article-title":"Effect of Transmitted Drug Resistance on Virological and Immunological Response to Initial Combination Antiretroviral Therapy for HIV (EuroCoord-CHAIN Joint Project): A European Multicohort Study","volume":"11","author":"L Wittkop","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"ref25","doi-asserted-by":"crossref","first-page":"e26757","DOI":"10.1371\/journal.pone.0026757","article-title":"Increase of Transmitted Drug Resistance among HIV-Infected sub-Saharan Africans Residing in Spain in Contrast to the Native Population","volume":"6","author":"G Yebra","year":"2011","journal-title":"PLoS One"},{"issue":"00","key":"ref26","first-page":"1","article-title":"High Prevalence of Transmitted Antiretroviral Drug Resistance among Newly HIV Type 1 Diagnosed Adults in Mombasa, Kenya","volume":"27","author":"KCE Sigallof","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"10","key":"ref27","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S1473-3099(11)70149-9","article-title":"HIV-1 Drug Resistance in Antiretroviral-Na\u00efve Individuals in sub-Saharan Africa after Rollout of Antiretroviral Therapy: A Multicentre Observational Study","volume":"11","author":"RL Hamers","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 2","key":"ref28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/135965350801302S08","article-title":"Surveillance of Transmitted HIV Drug Resistance among Women Attending Antenatal Clinics in Dar es Salaam, Tanzania","volume":"13","author":"GR Somi","year":"2008","journal-title":"Antivir Ther"},{"issue":"9","key":"ref29","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1089\/aid.2014.0043","article-title":"Prevalence and Virologic Consequences of Transmitted HIV-1 Drug Resistance in Uganda","volume":"30","author":"GQ Lee","year":"2014","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"5","key":"ref30","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1089\/aid.2012.0123","article-title":"Short Communication: HIV Type 1 Transmitted Drug Resistance and Evidence Antiretroviral-Na\u00efve Individuals from Ugandan Fishing Communities of Lake Victoria","volume":"29","author":"N Ndembi","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"12","key":"ref31","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1089\/aid.2012.0090","article-title":"Low Drug Resistance Levels among Drug-Naive Individuals with Recent HIV Type 1 Infection in a Rural Clinical Cohort in Southwestern Uganda","volume":"28","author":"D Ssemwanga","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"12","key":"ref32","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1089\/aid.2009.0007","article-title":"HIV Type 1 Subtype Diversity and Drug Resistance among HIV Type 1-Infected Kenyan Patients Initiating Antiretroviral Therapy","volume":"25","author":"RW Lihana","year":"2009","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"6","key":"ref33","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1089\/aid.2007.0317","article-title":"Transmitted Antiretroviral Drug Resistance Surveillance among Newly HIV Type 1-Diagnosed Women Attending an Antenatal Clinic in Entebbe, Uganda","volume":"24","author":"N Ndembi","year":"2008","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref34","unstructured":"WHO. Meeting Report on Framework for Metrics to Support Effective Treatment as Prevention. 2012."},{"issue":"6","key":"ref35","doi-asserted-by":"crossref","first-page":"e1001045","DOI":"10.1371\/journal.pmed.1001045","article-title":"More and Better Information to Tackle HIV Epidemics: Towards Improved HIV Incidence Assays","volume":"8","year":"2011","journal-title":"PLoS Med"},{"issue":"Suppl 2","key":"ref36","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1093\/infdis\/jit107","article-title":"Emergence of HIV Drug Resistance During First- and Second-Line Antiretroviral Therapy in Resource-Limited Settings","volume":"207","author":"MC Hosseinipour","year":"2013","journal-title":"J Infect Dis"},{"key":"ref37","unstructured":"Maman D, Masson S, Riche B. Ndhiwa HIV Impact in Population Survey. 2014."},{"key":"ref38","unstructured":"Ministry of Health. Kenya HIV Prevention Revolution Road Map\u2014Count Down To 2030. 2014."},{"issue":"11","key":"ref39","doi-asserted-by":"crossref","first-page":"e28184","DOI":"10.1371\/journal.pone.0028184","article-title":"Optimization of a Low Cost and Broadly Sensitive Genotyping Assay for HIV-1 Drug Resistance Surveillance and Monitoring in Resource-Limited Settings","volume":"6","author":"Z Zhou","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"ref40","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1128\/JCM.06689-11","article-title":"Automating HIV Drug Resistance Genotyping with RECall, A Freely Accessible Sequence Analysis Tool","volume":"50","author":"CK Woods","year":"2012","journal-title":"J Clin Microbiol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"W465","DOI":"10.1093\/nar\/gkn180","article-title":"Phylogeny.fr: Robust Phylogenetic Analysis for the Non-Specialist","volume":"36","author":"A Dereeper","year":"2008","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"ref42","doi-asserted-by":"crossref","first-page":"e4724","DOI":"10.1371\/journal.pone.0004724","article-title":"Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update","volume":"4","author":"DE Bennett","year":"2009","journal-title":"PLoS One"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000331998","article-title":"The HIVdb System for HIV-1 Genotypic Resistance Interpretation","volume":"5107","author":"MW Tang","year":"2012","journal-title":"Intervirology"},{"issue":"12","key":"ref44","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/molbev\/mst197","article-title":"MEGA6: Molecular Evolutionary Genetics Analysis version 6.0","volume":"30","author":"K Tamura","year":"2013","journal-title":"Mol Biol Evol"},{"issue":"2","key":"ref45","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1214\/ss\/1009213286","article-title":"Interval Estimation for a Binomial Proportion","volume":"16","author":"LD Brown","year":"2001","journal-title":"Stat Sci"},{"issue":"8","key":"ref46","doi-asserted-by":"crossref","first-page":"e40533","DOI":"10.1371\/journal.pone.0040533","article-title":"Transmitted Antiretroviral Drug Resistance in New York State, 2006\u20132008: Results from a New Surveillance System","volume":"7","author":"AC Readhead","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"ref47","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/infdis\/jiq167","article-title":"Differential Persistence of Transmitted HIV-1 Drug Resistance Mutation Classes","volume":"203","author":"V Jain","year":"2011","journal-title":"J Infect Dis"},{"key":"ref48","article-title":"HIV Prevention among Injection Drug Users in Kenya and Tanzania HIV Prevention among Injection Drug Users in Kenya and Tanzania","author":"P Nieburg","year":"2011"},{"issue":"9651","key":"ref49","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0140-6736(08)61311-2","article-title":"Global Epidemiology of Injecting Drug Use and HIV among People Who Inject Drugs: A systematic Review","volume":"372","author":"BM Mathers","year":"2008","journal-title":"Lancet"},{"issue":"10","key":"ref50","doi-asserted-by":"crossref","DOI":"10.1089\/aid.2013.0108","article-title":"Transmission Network of an HIV Type 1 Strain with K103N in Young Belgian Patients from Different Risk Groups","volume":"29","author":"J Ruelle","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"11","key":"ref51","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1128\/JVI.02579-07","article-title":"Persistence of Transmitted Drug Resistance among Subjects with Primary Human Immunodeficiency Virus Infection","volume":"82","author":"SJ Little","year":"2008","journal-title":"J Virol"},{"issue":"6","key":"ref52","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1086\/511276","article-title":"Horst C Van Der, Van Rie A. Survival in Women Exposed to Single-Dose Nevirapine for Prevention of Mother-To-Child Transmission of HIV: A Stochastic Model","volume":"195","author":"D Westreich","year":"2007","journal-title":"J Infect Dis"},{"issue":"Suppl 2","key":"ref53","doi-asserted-by":"crossref","first-page":"O14","DOI":"10.1186\/1742-4690-8-S2-O14","article-title":"Interactions of Different Drug Resistance Mutations in HIV Reverse Transcriptase in Defining Patterns of Drug Resistance","volume":"8","author":"MA Wainberg","year":"2011","journal-title":"Retrovirology"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1742-4690-6-54","article-title":"Multiple-Infection and Recombination in HIV-1 within a Longitudinal Cohort of Women","volume":"6","author":"AR Templeton","year":"2009","journal-title":"Retrovirology"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1742-4690-7-22","article-title":"Phylodynamics of HIV-1 Circulating Recombinant Forms 12_BF and 38_BF in Argentina and Uruguay","volume":"7","author":"G Bello","year":"2010","journal-title":"Retrovirology"},{"issue":"5","key":"ref56","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1089\/088922204323087822","article-title":"Genetic Diversity and High Proportion of Intersubtype Recombinants among HIV Type 1-Infected Pregnant Women in Kisumu, Western Kenya","volume":"20","author":"C Yang","year":"2004","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"4","key":"ref57","first-page":"287","article-title":"Impact of Genetic Diversity of HIV-1 on Diagnosis, Antiretroviral Therapy & Vaccine Development","volume":"121","author":"RB Lal","year":"2005","journal-title":"Indian J Med Res"},{"issue":"1","key":"ref58","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.aids.0000196172.35056.b7","article-title":"The Impact of Transmitted Drug Resistance on the Natural History of HIV Infection and Response to First-Line Therapy","volume":"20","author":"D Pillay","year":"2006","journal-title":"AIDS"},{"issue":"2","key":"ref59","first-page":"148","article-title":"Minority HIV mutation detection in dried blood spots indicates high specimen integrity and reveals hidden archived drug resistance","volume":"50","author":"X Wei","year":"2011","journal-title":"J Clin Microbiol"},{"key":"ref60","first-page":"625","article-title":"False recent rates for two recent infection testing algorithms, South Nyanza, Kenya","author":"C Zeh","year":"2015"},{"issue":"4","key":"ref61","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1089\/aid.2013.0169","article-title":"Impact of HIV subtype on performance of the limiting antigen-avidity enzyme immunoassay, the Bio-Rad Avidity Assay, and the BED Capture Immunoassay in Rakai, Uganda","volume":"30","author":"AF Longosz","year":"2014","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"6","key":"ref62","doi-asserted-by":"crossref","first-page":"e10952","DOI":"10.1371\/journal.pone.0010952","article-title":"Prevalence and Clinical Significance of HIV Drug Resistance Mutations by Ultra-Deep Sequencing in Antiretroviral-Na\u00efve Subjects in the CASTLE Study","volume":"5","author":"M Lataillade","year":"2010","journal-title":"PLoS One"},{"key":"ref63","unstructured":"Guha SK, Haldar SN. Drug Resistance in HIV. In: Medicine Update. 2012. p. 84\u20138."},{"issue":"11","key":"ref64","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.1128\/JVI.06541-11","article-title":"Deep Sequencing Reveals Minor Protease Resistance Mutations in Patients Failing a Protease Inhibitor Regimen","volume":"86","author":"R Fisher","year":"2012","journal-title":"J Virol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0171124","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T20:59:11Z","timestamp":1658609951000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0171124"}},"subtitle":[],"editor":[{"given":"Luis","family":"Men\u00e9ndez-Arias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,2,8]]},"references-count":64,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,2,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0171124","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,8]]}}}